SG141418A1 - Method for the detection of gene transcripts in blood and uses thereof - Google Patents

Method for the detection of gene transcripts in blood and uses thereof

Info

Publication number
SG141418A1
SG141418A1 SG200719158-8A SG2007191588A SG141418A1 SG 141418 A1 SG141418 A1 SG 141418A1 SG 2007191588 A SG2007191588 A SG 2007191588A SG 141418 A1 SG141418 A1 SG 141418A1
Authority
SG
Singapore
Prior art keywords
disease
blood
detection
diagnosing
gene transcripts
Prior art date
Application number
SG200719158-8A
Other languages
English (en)
Inventor
Choong-Chin Liew
Original Assignee
Genenews Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/601,518 external-priority patent/US20070031841A1/en
Application filed by Genenews Inc filed Critical Genenews Inc
Publication of SG141418A1 publication Critical patent/SG141418A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
SG200719158-8A 2003-06-20 2004-06-21 Method for the detection of gene transcripts in blood and uses thereof SG141418A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/601,518 US20070031841A1 (en) 2001-02-28 2003-06-20 Method for the detection of gene transcripts in blood and uses thereof
US10/809,675 US20050123938A1 (en) 1999-01-06 2004-03-25 Method for the detection of osteoarthritis related gene transcripts in blood

Publications (1)

Publication Number Publication Date
SG141418A1 true SG141418A1 (en) 2008-04-28

Family

ID=33544775

Family Applications (1)

Application Number Title Priority Date Filing Date
SG200719158-8A SG141418A1 (en) 2003-06-20 2004-06-21 Method for the detection of gene transcripts in blood and uses thereof

Country Status (7)

Country Link
US (6) US20050123938A1 (de)
EP (1) EP1643893A4 (de)
JP (1) JP2007528704A (de)
AU (1) AU2004249318A1 (de)
CA (1) CA2530191A1 (de)
SG (1) SG141418A1 (de)
WO (1) WO2004112589A2 (de)

Families Citing this family (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070105105A1 (en) * 2003-05-23 2007-05-10 Mount Sinai School Of Medicine Of New York University Surrogate cell gene expression signatures for evaluating the physical state of a subject
US20050221383A1 (en) * 2003-08-08 2005-10-06 Choong-Chin Liew Osteoarthritis biomarkers and uses thereof
AU2004284434A1 (en) * 2003-10-16 2005-05-06 Genomic Health, Inc. qRT-PCR assay system for gene expression profiling
US20050208519A1 (en) * 2004-03-12 2005-09-22 Genenews Inc. Biomarkers for diagnosing schizophrenia and bipolar disorder
GB0412301D0 (en) 2004-06-02 2004-07-07 Diagenic As Product and method
WO2006007664A1 (en) * 2004-07-22 2006-01-26 Genomics Research Partners Pty Ltd Agents and methods for diagnosing osteoarthritis
CA2599589A1 (en) * 2005-02-07 2006-08-17 Genenews,Inc. Mild osteoarthritis biomarkers and uses thereof
JP5109131B2 (ja) 2005-02-10 2012-12-26 オンコセラピー・サイエンス株式会社 膀胱癌を診断する方法
EP2290363B1 (de) * 2005-03-11 2014-01-08 Firalis SAS Biomarker für durch cox-2 inhibierende Substanzen verursachte kardiovaskuläre Nebenwirkungen
KR101545020B1 (ko) * 2005-05-02 2015-08-17 도레이 카부시키가이샤 식도암 및 식도암 전이 진단을 위한 조성물 및 방법
JP4929277B2 (ja) * 2005-05-30 2012-05-09 武田薬品工業株式会社 神経変性疾患に対する診断上及び治療上の標的ｐｒｋｘタンパク質
WO2007026895A1 (ja) * 2005-09-02 2007-03-08 Toray Industries, Inc. 尿路上皮ガンの検出用キットおよび方法
JP4870976B2 (ja) * 2005-11-10 2012-02-08 株式会社Ｄｎａチップ研究所 全血を用いた自己免疫疾患の検査方法
US20080075789A1 (en) * 2006-02-28 2008-03-27 The Regents Of The University Of California Genes differentially expressed in bipolar disorder and/or schizophrenia
US7943310B2 (en) * 2006-08-30 2011-05-17 Centocor Ortho Biotech Inc. Methods for assessing response to therapy in subjects having ulcerative colitis
US8158374B1 (en) 2006-09-05 2012-04-17 Ridge Diagnostics, Inc. Quantitative diagnostic methods using multiple parameters
US20080082306A1 (en) * 2006-09-29 2008-04-03 Searete Llc Computational systems for biomedical data
US20080091730A1 (en) * 2006-09-29 2008-04-17 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational systems for biomedical data
US20080082364A1 (en) * 2006-09-29 2008-04-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational systems for biomedical data
US10095836B2 (en) * 2006-09-29 2018-10-09 Gearbox Llc Computational systems for biomedical data
US20080082271A1 (en) * 2006-09-29 2008-04-03 Searete Llc Computational systems for biomedical data
US20080082367A1 (en) * 2006-09-29 2008-04-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational systems for biomedical data
US10068303B2 (en) 2006-09-29 2018-09-04 Gearbox Llc Computational systems for biomedical data
US10503872B2 (en) * 2006-09-29 2019-12-10 Gearbox Llc Computational systems for biomedical data
US20080082359A1 (en) * 2006-09-29 2008-04-03 Searete Llc, A Limited Liability Corporation Of State Of Delaware Computational systems for biomedical data
US10546652B2 (en) * 2006-09-29 2020-01-28 Gearbox Llc Computational systems for biomedical data
US20080082584A1 (en) * 2006-09-29 2008-04-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational systems for biomedical data
US20080109484A1 (en) * 2006-09-29 2008-05-08 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational systems for biomedical data
US8122073B2 (en) 2006-09-29 2012-02-21 The Invention Science Fund I Computational systems for biomedical data
US20080082307A1 (en) * 2006-09-29 2008-04-03 Searete Llc Computational systems for biomedical data
CN101568550B (zh) 2006-10-17 2012-12-26 肿瘤疗法科学股份有限公司 用于表达mphosph1或depdc1多肽的癌症的肽疫苗
WO2008124428A1 (en) * 2007-04-03 2008-10-16 Indiana University Research And Technology Corporation Blood biomarkers for mood disorders
US8187810B2 (en) * 2007-05-16 2012-05-29 Wellman Wai-Man Cheung Method for diagnosing overactive bladder
US8440418B2 (en) * 2008-11-18 2013-05-14 Ridge Diagnostics, Inc. Metabolic syndrome and HPA axis biomarkers for major depressive disorder
FR2929292A1 (fr) 2008-03-28 2009-10-02 Exonhit Therapeutics S A Sa Procede et methodes de diagnostic de la maladie d'alzheimer
JP2011517941A (ja) * 2008-04-10 2011-06-23 ジーンニュース・コーポレーション 被験者における結腸直腸癌の確率を決定するための方法および装置
AU2009240021B2 (en) * 2008-04-21 2013-01-10 Novartis Forschungsstiftung, Zweigniederlassung Friedrich Miescher Institute For Biomedical Research Antiviral therapy
WO2010012086A1 (en) * 2008-07-28 2010-02-04 Genenews Corporation Methods and compositions for determining severity of heart failure in a subject
US8975086B2 (en) 2008-08-28 2015-03-10 Oncotherapy Science, Inc. Method for treating or preventing bladder cancer using the DEPDC1 polypeptide
JP2010057407A (ja) * 2008-09-03 2010-03-18 Srl Inc 双極性障害と統合失調症の判別方法
WO2010029167A2 (en) * 2008-09-12 2010-03-18 Universitätsklinikum Münster Means and methods for evaluating a therapy with a p38 map kinase inhibitor
US20100105054A1 (en) * 2008-10-15 2010-04-29 Cincinnati Children's Hospital Medical Center Gene expression in duchenne muscular dystrophy
JP5540000B2 (ja) * 2008-10-15 2014-07-02 リッジ ダイアグノスティックス，インコーポレイテッド うつ病性障害のヒトバイオマーカーハイパーマッピング
US20110229471A1 (en) 2008-11-26 2011-09-22 Cedars-Sinai Medical Center Methods of determining responsiveness to anti-tnf alpha therapy in inflammatory bowel disease
CA2757518A1 (en) * 2009-04-01 2010-10-07 Ridge Diagnostics, Inc. Biomarkers for monitoring treatment of neuropsychiatric diseases
EP2417448A4 (de) * 2009-04-06 2012-10-24 Ridge Diagnostics Inc Biomarker zur überwachung der behandlung von neuropsychiatrischen erkrankungen
US20120073585A1 (en) * 2009-04-08 2012-03-29 Cedars-Sinai Medical Center Methods of predicting complication and surgery in crohn's disease
KR100964193B1 (ko) * 2009-04-17 2010-06-16 씨비에스바이오사이언스 주식회사 간암 예후 마커
JP6081195B2 (ja) 2009-05-11 2017-02-15 バーグ エルエルシー エピメタボリックシフター、多次元細胞内分子、または環境影響因子を使用する腫瘍性障害の診断のための方法
AU2010276392A1 (en) * 2009-07-20 2012-03-08 Genentech, Inc. Gene expression markers for Crohn's disease
CA2788315A1 (en) * 2010-01-26 2011-08-04 Ridge Diagnostics, Inc. Multiple biomarker panels to stratify disease severity and monitor treatment of depression
EP2921562B1 (de) * 2010-05-27 2017-03-08 The University of Tokyo Verfahren zum nachweis von adipositasrisiko
US10318877B2 (en) 2010-10-19 2019-06-11 International Business Machines Corporation Cohort-based prediction of a future event
US20120095775A1 (en) * 2010-10-19 2012-04-19 International Business Machines Corporation Characterizing, tracking and optimizing population health based on integration of multi-disciplinary databases
EP2643476A1 (de) * 2010-11-24 2013-10-02 F.Hoffmann-La Roche Ag Verfahren für den nachweis von low-grade-entzündungen
US9902996B2 (en) 2011-02-11 2018-02-27 Cedars-Sinai Medical Center Methods of predicting the need for surgery in crohn's disease
CN103608323B (zh) 2011-04-04 2016-08-17 博格有限责任公司 治疗中枢神经系统肿瘤的方法
SG11201505515XA (en) * 2012-01-27 2015-09-29 Univ Leland Stanford Junior Methods for profiling and quantitating cell-free rna
EP2647726A1 (de) * 2012-04-05 2013-10-09 Universitätsklinikum Freiburg Kardiovaskuläre Biomarker
JP5963198B2 (ja) 2012-09-26 2016-08-03 国立研究開発法人科学技術振興機構 動的ネットワークバイオマーカーの検出装置、検出方法及び検出プログラム
EP2978440B1 (de) 2013-03-27 2019-10-02 Cedars-Sinai Medical Center Behandlung von fibrose durch tl1a-hemmung und diagnose von fibrose durch il31ra-nachweis
US10933032B2 (en) 2013-04-08 2021-03-02 Berg Llc Methods for the treatment of cancer using coenzyme Q10 combination therapies
WO2015010108A1 (en) 2013-07-19 2015-01-22 Cedars-Sinai Medical Center Signature of tl1a (tnfsf15) signaling pathway
IL276423B2 (en) 2013-09-04 2024-05-01 Berg Llc Pharmaceutical preparations containing coenzyme Q10 for use in cancer treatment
KR20180033585A (ko) 2015-08-12 2018-04-03 온코세라피 사이언스 가부시키가이샤 Depdc1-유래 펩티드 및 이를 포함하는 백신
US11186872B2 (en) 2016-03-17 2021-11-30 Cedars-Sinai Medical Center Methods of diagnosing inflammatory bowel disease through RNASET2
RU2019109212A (ru) * 2016-09-01 2020-10-01 Дзе Джордж Вашингтон Юниверсити Рнк-биомаркеры крови ишемической болезни сердца
JP2018005925A (ja) * 2017-08-10 2018-01-11 国立研究開発法人科学技術振興機構 バイオマーカーの候補及び治療用製薬
US11751851B2 (en) * 2021-08-31 2023-09-12 Duke University Methods, systems and computer program products for tissue analysis using ultrasonic backscatter coherence

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5352775A (en) * 1991-01-16 1994-10-04 The Johns Hopkins Univ. APC gene and nucleic acid probes derived therefrom
EP0644889A4 (de) * 1991-12-24 1996-01-10 Isis Pharmaceuticals Inc ZUSAMMENSETZUNGEN UND VERFAHREN ZUR MODULATION VON-g(b)-AMYLOID.
US5968770A (en) * 1995-02-10 1999-10-19 Millennium Pharmaceuticals, Inc. Compositions and methods for the treatment and diagnosis of cardiovascular disease using rchd523 as a target
US5775329A (en) * 1995-06-07 1998-07-07 Gensia, Inc. Method and compounds for diagnosing coronary artery disease
EP0951541B1 (de) * 1995-07-31 2005-11-30 Urocor, Inc. Biomarker und ziele für die diagnose, prognose und handhabung von prostatkrebs
US6218529B1 (en) * 1995-07-31 2001-04-17 Urocor, Inc. Biomarkers and targets for diagnosis, prognosis and management of prostate, breast and bladder cancer
CA2247246A1 (en) * 1996-02-16 1997-08-21 Millennium Pharmaceuticals, Inc. Compositions and methods for the treatment and diagnosis of cardiovascular disease
FR2775984B1 (fr) * 1998-03-11 2006-09-15 Bioscreen Therapeutics Sa Criblage differentiel qualitatif
US6630301B1 (en) * 1997-03-14 2003-10-07 The Penn State Research Foundation Detection of extracellular tumor-associated nucleic acid in blood plasma or serum
US5942385A (en) * 1996-03-21 1999-08-24 Sugen, Inc. Method for molecular diagnosis of tumor angiogenesis and metastasis
US6607898B1 (en) * 1996-03-26 2003-08-19 Oncomedx, Inc. Method for detection of hTR and hTERT telomerase-associated RNA in plasma or serum
US5739432A (en) * 1996-05-30 1998-04-14 The Regents Of The University Of California Ultrasonic characterization of single drops of liquids
US6479263B1 (en) * 1996-11-14 2002-11-12 Baylor College Of Medicine Method for detection of micrometastatic prostate cancer
WO1998024935A1 (en) * 1996-12-06 1998-06-11 Urocor, Inc. Diagnosis of disease state using mrna profiles
US5830668A (en) * 1996-12-13 1998-11-03 Immunosciences Lab, Inc. Detection of chronic fatigue syndrome
US6190857B1 (en) * 1997-03-24 2001-02-20 Urocor, Inc. Diagnosis of disease state using MRNA profiles in peripheral leukocytes
NO972006D0 (no) * 1997-04-30 1997-04-30 Forskningsparken I Aas As Ny metode for diagnose av sykdommer
US6525185B1 (en) * 1998-05-07 2003-02-25 Affymetrix, Inc. Polymorphisms associated with hypertension
US6521420B1 (en) * 1998-09-04 2003-02-18 Trustees Of Tufts College Hypertension associated transcription factors and uses therefor
US6486299B1 (en) * 1998-09-28 2002-11-26 Curagen Corporation Genes and proteins predictive and therapeutic for stroke, hypertension, diabetes and obesity
US6709855B1 (en) * 1998-12-18 2004-03-23 Scios, Inc. Methods for detection and use of differentially expressed genes in disease states
US6277574B1 (en) * 1999-04-09 2001-08-21 Incyte Genomics, Inc. Genes associated with diseases of the kidney
US6692916B2 (en) * 1999-06-28 2004-02-17 Source Precision Medicine, Inc. Systems and methods for characterizing a biological condition or agent using precision gene expression profiles
FR2798673B1 (fr) * 1999-09-16 2004-05-28 Exonhit Therapeutics Sa Methodes et compositions pour la detection d'evenements pathologiques
WO2001065259A1 (fr) * 2000-03-02 2001-09-07 Genox Research, Inc. Methode d'examen de maladies allergiques
US6974667B2 (en) * 2000-06-14 2005-12-13 Gene Logic, Inc. Gene expression profiles in liver cancer
AU2001276957A1 (en) * 2000-07-17 2002-01-30 Advanced Research And Technology Institute Method of diagnosing pulmonary hypertension
US6602718B1 (en) * 2000-11-08 2003-08-05 Becton, Dickinson And Company Method and device for collecting and stabilizing a biological sample
WO2003008647A2 (en) * 2000-11-28 2003-01-30 University Of Cincinnati Blood assessment of injury
CA2451074C (en) * 2001-06-18 2014-02-11 Rosetta Inpharmatics, Inc. Diagnosis and prognosis of breast cancer patients

Also Published As

Publication number Publication date
WO2004112589A2 (en) 2004-12-29
JP2007528704A (ja) 2007-10-18
EP1643893A4 (de) 2007-12-05
WO2004112589A3 (en) 2008-12-11
US20120165212A1 (en) 2012-06-28
US20130324434A1 (en) 2013-12-05
CA2530191A1 (en) 2004-12-29
EP1643893A2 (de) 2006-04-12
AU2004249318A1 (en) 2004-12-29
US20130102484A1 (en) 2013-04-25
US20050123938A1 (en) 2005-06-09
US20070054282A1 (en) 2007-03-08
US20110065602A1 (en) 2011-03-17

Similar Documents

Publication Publication Date Title
SG141418A1 (en) Method for the detection of gene transcripts in blood and uses thereof
TW200643175A (en) Markers for prenatal diagnosis and monitoring
WO2005040396A3 (en) qRT-PCR ASSAY SYSTEM FOR GENE EXPRESSION PROFILING
WO2006089091A3 (en) Methods for detecting minimum residual disease
WO2007001342A3 (en) Exhaled breath condensate collection and assay system and method
WO2005098445A3 (en) Lung cancer biomarkers
WO2005083440A3 (en) Identification of cancer protein biomarkers using proteomic techniques
WO2005000098A3 (en) Detection methods for disorders of the lung
ATE548467T1 (de) Verfahren zur identifizierung von biomarkern mit eignung bei der diagnose biologischer zustände
DE60239470D1 (de) Verfahren zur bewertung pathologischer krankheitszustände unter verwendung extrazellulärer rna
WO2004099432A3 (en) Identification of biomarkers for detecting pancreatic cancer
WO2010033371A3 (en) Molecular markers for lung and colorectal carcinomas
PL2341344T3 (pl) Sposób diagnozowania wielotorbielowatości nerek
WO2005103719A3 (en) Using plasma proteomic pattern for diagnosis, classification, prediction of response to therapy and clinical behavior, stratification of therapy, and monitoring disease in hematologic malignancies
MX2007016136A (es) Metodo para diagnosticar la enfermedad de alzheimer.
WO2008089072A3 (en) Proteomic profiling method useful for condition diagnosis and monitoring, composition screening, and therapeutic monitoring
WO2007030949A3 (en) Methods of diagnosing ovarian cancer and kits therefor
ATE446385T1 (de) Polymorphismen im nod2/card15 gen
WO2007070560A3 (en) Method for identification and monitoring of epigenetic modifications
WO2006092729A3 (en) Novel biomarkers for diagnosis and/or prognosis or prognosis of neoplasias in animals
WO2007106762A3 (en) Alzheimer's disease biomarkers and methods of use
WO2006002240A8 (en) Computer systems and methods for constructing biological classifiers and uses thereof
WO2006110748A3 (en) Response gene to complement 32 (rgc-32) in disease
MY145455A (en) Diagnostic biomolecule(s)
WO2003076896A3 (en) Use of biomarkers to detect breast cancer